Filip Dubovsky, MD, MPH is the Vice President, Clinical Development for Vaccines at MedImmune. Prior to joining MedImmune, Dr. Dubovsky held several roles of increasing responsibility in support of the Malaria Vaccine Initiative, PATH, including creating, managing and defending a portfolio of 25 malaria vaccine candidates spanning from early candidate optimization to Phase 3 clinical trial preparation. He also previously served in a clinical capacity at Stanford University, University of Maryland and John’s Hopkins University hospitals. Dr. Dubovsky received a bachelor’s degree in cell biology from Cornell University, a medical degree from the University of Alabama and a master’s of public health degree from John’s Hopkins University. Dr. Dubovsky completed his pediatric training at Stanford University and pediatric infectious disease fellowship at the Center for Vaccine Development at the University of Maryland